Effect of Brewer's Yeast-Induced Pyrexia on Aminophylline-Elicited Convulsions in Mice by Ochi, Rika et al.
Acta Medica Okayama
Volume 63, Issue 5 2009 Article 7
OCTOBER 2009
Effect of Brewer’s Yeast-Induced Pyrexia on
Aminophylline-Elicited Convulsions in Mice
Rika Ochi∗ Katsuya Suemaru†
Hiromu Kawasaki‡ Hiroaki Araki∗∗
∗Department of Clinical Pharmaceutical Science, Okayama University Graduate School of
Medicine, Dentistry and Pharmaceutical Sciences,
†Department of Clinical Pharmacology and Pharmacy, Ehime University Graduate School of
Medicine,
‡Department of Clinical Pharmaceutical Science, Okayama University Graduate School of
Medicine, Dentistry and Pharmaceutical Sciences,
∗∗Department of Clinical Pharmaceutical Science, Okayama University Graduate School of
Medicine, Dentistry and Pharmaceutical Sciences,
Copyright c©1999 OKAYAMA UNIVERSITY MEDICAL SCHOOL. All rights reserved.
Effect of Brewer’s Yeast-Induced Pyrexia on
Aminophylline-Elicited Convulsions in Mice
Rika Ochi, Katsuya Suemaru, Hiromu Kawasaki, and Hiroaki Araki
Abstract
Theophylline-associated convulsions have been observed most frequently in children with
fever, but the mechanism is not fully understood. In this study, we investigated the basic mech-
anism of aminophylline [theophylline-2-ethylenediamine]-induced convulsions and the effects of
Brewer’s yeast-induced pyrexia in mice. Diazepam (5-10mg/kg, i.p.), a benzodiazepine receptor
agonist, significantly prolonged the onset and significantly decreased the incidence of convulsions
induced by aminophylline (350mg/kg, i.p.). However, the gamma aminobutyric acid (GABA)A
receptor agonist muscimol (1-4mg/kg, i.p.), the GABAB receptor agonist baclofen (2-4mg/kg,
i.p.) and the N-methyl-D-aspartic acid receptor antagonist dizocilpine (0.1-0.3mg/kg, i.p.) failed
to protect against the convulsions. 20% Brewer’s yeast (0.02ml/g, s.c.) increased body tempera-
ture by 1.03, and also significantly shortened the onset and significantly increased the incidence of
convulsions induced by aminophylline. The anticonvulsant action of diazepam (2.5-10mg/kg, i.p.)
on the convulsions induced by aminophylline was reduced by Brewer’s yeast-induced pyrexia.
The proconvulsant actions of the GABAA receptor antagonists picrotoxin (3-4mg/kg, i.p.) and
pentylenetetrazol (40-60mg/kg, i.p.) were enhanced by Brewer’s yeast. These results suggest that
the anticonvulsant action of diazepam against aminophylline is reduced by Brewer’s yeast-induced
pyrexia, and that GABAA receptors are involved in the aggravation of the convulsions by Brewer’s
yeast in mice.
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Theophylline-associated convulsions have been observed most frequently in children with fever,  but the 
mechanism is not fully understood.  In this study,  we investigated the basic mechanism of aminophyl-
line [theophylline-2-ethylenediamine]-induced convulsions and the eﬀects of Brewerʼs yeast-induced 
pyrexia in mice.  Diazepam (5-10mg/kg,  i.p.),  a benzodiazepine receptor agonist,  signiﬁcantly pro-
longed the onset and signiﬁcantly decreased the incidence of convulsions induced by aminophylline 
(350mg/kg,  i.p.).  However,  the gamma aminobutyric acid (GABA)A receptor agonist muscimol 
(1-4mg/kg,  i.p.),  the GABAB receptor agonist baclofen (2-4mg/kg,  i.p.) and the N-methyl-D-aspartic 
acid receptor antagonist dizocilpine (0.1-0.3mg/kg,  i.p.) failed to protect against the convulsions.  20ｵ 
Brewerʼs yeast (0.02ml/g,  s.c.) increased body temperature by 1.03℃,  and also signiﬁcantly shortened 
the onset and signiﬁcantly increased the incidence of convulsions induced by aminophylline.  The anti-
convulsant action of diazepam (2.5-10mg/kg,  i.p.) on the convulsions induced by aminophylline was 
reduced by Brewerʼs yeast-induced pyrexia.  The proconvulsant actions of the GABAA receptor 
antagonists picrotoxin (3-4mg/kg,  i.p.) and pentylenetetrazol (40-60mg/kg,  i.p.) were enhanced by 
Brewerʼs yeast.  These results suggest that the anticonvulsant action of diazepam against aminophyl-
line is reduced by Brewerʼs yeast-induced pyrexia,  and that GABAA receptors are involved in the 
aggravation of the convulsions by Brewerʼs yeast in mice.
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heophylline is widely used as a bronchodilator 
in neonatal apnea,  but it runs the risk of toxic-
ity and associated convulsions [1].  Therapeutic drug 
monitoring of theophylline is thus important to avoid 
this adverse reaction [2].  However,  several reports 
have shown that theophylline at therapeutic doses 
occasionally induces convulsions and status epilepticus 
in children,  particularly at pre-school age [1,  3].  
The current Japanese Asthma Guidelines (2005) rec-
ommend that theophylline should be avoided in chil-
dren under 6 months of age,  and in children more than 
6 months of age with prior seizures and/or other 
neurological abnormalities [4].  In addition,  in chil-
dren,  it is recommend that the dosage of theophylline 
should be reduced or the drug withdrawn,  if fever 
occurs [4].
　 Theophylline is a very potent central nervous sys-
tem stimulant,  and most of its pharmacological eﬀects 
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can be linked to the blockade of adenosine receptors 
and inhibition of phosphodiesterase.  Benzodiazepines 
are widely used as anticonvulsants against theophyl-
line-induced convulsions,  and it is well known that 
benzodiazepines are agonists for the gamma-aminobu-
tyric acid (GABA)A receptor complex [5].  Previous 
studies using various models of convulsions have 
shown the involvements of adenosine receptor [6-8],  
GABA receptor [9],  benzodiazepine receptor [10],  
and N-methyl-D-aspartic acid (NMDA) receptor [11,  
12] in the proconvulsant action of theophylline.  
However,  the precise mechanisms of the proconvul-
sant eﬀect of theophylline underlying fever are not 
clear.
　 The ﬁrst aim of this study was to evaluate the basic 
mechanism of theophylline-induced convulsions.  The 
second aim was to clarify the eﬀect of fever on the 
proconvulsant eﬀect.  Aminophylline is a water-soluble 
theophylline compound with ethylenediamine.  It is well 
documented that the central nervous system stimulant 
properties of aminophylline are due to its theophylline 
component,  since ethylenediamine has no convulsive 
potential [13].  Thus,  in this study,  to evaluate the 
basic mechanism of theophylline-induced convulsions,  
the convulsion-ameliorating eﬀects of drugs acting on 
adenosine,  NMDA,  GABA and benzodiazepine recep-
tors were investigated in mice.  On the other hand,  
Brewerʼs yeast-induced pyrexia has been used as a 
screening tool for antipyretic agents in rodents [14].  
Therefore,  we investigated the eﬀects of fever on 
aminophylline-induced convulsions using the Brewerʼs 
yeast-induced pyrexia.  In addition,  to clarify the 
involvement of GABAA receptors in the proconvulsant 
eﬀect of fever,  the changes in the threshold of convul-
sion induced by GABAA receptor antagonists were 
investigated.
Materials and Methods
　 Animals. Male ddY mice (at 6-7 weeks of age) 
were obtained from SLC Co.,  Ltd.,  (Shizuoka,  
Japan).  All of the animals were housed in groups of 
ﬁve per plastic cage (18×44×27cm) in a room main-
tained at 22±2℃ under a 12/12h light/dark cycle 
with lights on at 07:00 a.m.  The experimental proto-
col was conducted according to the Guidelines of the 
Ethics Review Committee for Animal Experimentation 
of Ehime University Medical School.
　 Drugs. The following drugs were used: amino-
phylline (theophylline-2-ethylenediamine,  Neophylline® 
injection Eisai Co.,  Tokyo,  Japan),  2-chloro-N6-cy-
clopentyladenosine (CCPA,  adenosine A1 receptor 
agonist Sigma-Aldrich Inc.,  St.  Louis,  MO,  USA),  
N6-cyclopentyladenosine (CPA,  adenosine A1 receptor 
agonist Sigma-Aldrich Inc.),  5ʼ-(N-cyclopropyl) car-
boxamidoadenosine (CPCA,  adenosine A2 receptor 
agonist Sigma-Aldrich),  dizocilpine maleate (NMDA 
receptor antagonist Sigma-Aldrich),  muscimol 
(GABAA receptor agonist Sigma-Aldrich),  (±) bac-
lofen (GABAB receptor agonist Sigma-Aldrich),  pen-
tylenetetrazol (GABAA receptor antagonist Wako 
Pure Chemical Industries,  Ltd.  Osaka,  Japan),  
picrotoxin (GABAA receptor antagonist Sigma-
Aldrich) and diazepam (benzodiazepine receptor ago-
nist Wako).  Diazepam was dissolved in 10ｵ polyeth-
ylene glycol.  The other drugs were dissolved in saline.  
All drugs were injected i.p.  at a volume of 0.1ml per 
10g body weight.
　 Induction of pyrexia. Induction of pyrexia 
was based on a method of Bhat et al.  [14].  After 
recording the rectal temperature of each of the ani-
mals in a batch,  pyrexia was induced by subcutaneous 
injection of 20ｵ Brewerʼs yeast suspension (Sigma-
Aldrich) in the neck scruﬀ at a volume of 0.02ml/g 
body weight.  Animals were fasted and 18h later,  on 
the following day,  the rectal temperature of each 
animal was recorded by a digital thermometer.  The 
mice exhibiting a rise in temperature of more than 
0.8℃ were considered pyretic [14] and all the 
pyretic animals were randomly administered saline or 
drugs.
　 Aminophylline-induced convulsions. Experi-
ments were carried out with graded single doses of 
aminophylline from 250-350mg/kg administered i.p.  
to mice.  After injection,  the mice were put into indi-
vidual plastic cages and observed for 60min to exam-
ine the following parameters:
　 a. Percent (ｵ) of animals having clonic convulsions
　 b. Latency of onset of clonic convulsions (min)
　 In mice which did not show any convulsions during 
the observation period of 1h,  the convulsion latency 
was taken as 60min for the purpose of data analysis.  
On the basis of the results obtained with various doses 
of aminophylline,  a dose producing clonic convulsions 
in 100ｵ of animals was selected for subsequent 
experiments to investigate the modulatory eﬀects of 
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diﬀerent drugs.  Aminophylline was injected 30min 
after the treatments (i.p.) with CCPA,  CPA,  CPCA,  
muscimol,  baclofen,  dizocilpine,  diazepam and saline.
　 Convulsions induced by GABAA receptor 
antagonists. To examine changes in the threshold 
of convulsion induced by GABAA receptor antagonists,  
mice were treated with various doses of picrotoxin 
(3-4mg/kg) and pentylenetetrazol (40-60mg/kg) 18h 
after the administration of 20ｵ Brewerʼs yeast 
(0.02ml/g,  s.c.) or saline.  The mice were then placed 
in isolated cages and observed for 60min after the 
administration of each convulsant drug.
　 Statistical analysis. All mean values of the 
data were presented with their standard error (S.E.).  
The latency of clonic convulsions by aminophylline-
induced convulsions was analyzed using one-way analy-
sis of variance (ANOVA) followed by Dunnettʼs test or 
Tukeyʼs test.  The incidence of clonic convulsions was 
assessed for signiﬁcance by the Chi-squared test for 
independence.  For the analysis of convulsion latency 
in saline- or Brewerʼs yeast-treated mice,  a two-way 
ANOVA with pyrogen factor and drug factor was 
used.  Whenever the pyrogen factor or the interaction 
of pyrogen factor×drug factor was signiﬁcant,  post 
hoc comparisons were performed with the Studentʼs 
t-test.  The criterion for statistical signiﬁcance was set 
at p＜0.05.
Results
　 Convulsant effect of aminophylline.
Aminophylline (250-350mg/kg,  i.p.) dose-dependently 
induced clonic convulsions in mice (Fig.  1).  The con-
vulsions were characterized by a raised tail,  relatively 
wild running,  and violent body movement followed by 
loss of the righting reﬂex and ﬁnally extension of the 
hind limbs.
　 Convulsion-ameliorating eﬀects of drugs act-
ing on adenosine, NMDA, GABA and benzodi-
azepine receptors. A benzodiazepine receptor 
agonist,  diazepam (5-10mg/kg,  i.p.),  signiﬁcantly 
prolonged the onset of aminophylline (350mg/kg,  
i.p.)-elicited convulsions,  and it signiﬁcantly reduced 
the number of animals convulsing (Table 1).  However,  
the adenosine A1 receptor agonists CCPA (1-10mg/
kg,  i.p.) and CPA (3-20mg/kg,  i.p.),  the adenosine A2 
receptor agonist CPCA (3-20mg/kg,  i.p.),  the 
GABAA receptor agonist muscimol (1-4mg/kg,  i.p.),  
the GABAB receptor agonist baclofen (2-4mg/kg,  
i.p.) and the NMDA receptor antagonist dizocilpine 
(0.1-0.3mg/kg,  i.p.) did not signiﬁcantly alter amino-
phylline convulsions.
　 Eﬀects of Brewerʼs yeast on body tempera-
ture. Subcutaneous administration of 20ｵ 
Brewerʼs yeast (0.02ml/g) induced a signiﬁcant 
increase in rectal temperature of saline-treated control 
mice (1.03±0.17℃,  n＝10,  p＜0.01,  paired Stu-
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Fig. 1　 Convulsant eﬀect of aminophylline in mice.  Each column represents the incidence (%) and the mean latency (min) with S.E.M. 
of convulsions induced by aminophylline (250-350mg/kg,  i.p.) in mice (n＝10).
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dentʼs t-test) in comparison to the initial rectal tem-
perature 18h before (37.49±0.24℃).  The other 
groups of mice also showed signiﬁcant increases in 
rectal temperature by the administration of 20ｵ 
Brewerʼs yeast (data not shown).
　 Eﬀects of aminophylline-induced convulsions 
in Brewerʼs yeast-treated mice. The Brewerʼs 
yeast signiﬁcantly increased the incidence of convul-
sions induced by aminophylline (200-300mg/kg,  i.p.) 
(Fig.  2).  Two-way ANOVA revealed that Brewerʼs 
yeast treatment signiﬁcantly shortened the onset of the 
convulsions induced by aminophylline [pyrogen: F (1,  
52)＝10.063,  p＜0.001; drug: F (2,  52)＝9.406,  p
＜0.001; interaction: F (2,  50)＝1.495,  p＞0.05].  
The post hoc comparison using the Studentʼs t-test 
revealed signiﬁcant diﬀerences in the latency of the 
convulsions at doses of 250 and 300mg/kg of amino-
phylline.
　 Eﬀects of diazepam on aminophylline-
induced convulsions in Brewerʼs yeast-treated 
mice. The anticonvulsant action of diazepam (2.5-
10mg/kg,  i.p.) on convulsions induced by aminophyl-
line (350mg/kg,  i.p.) was reduced by 20ｵ Brewerʼs 
yeast.  There was no signiﬁcant diﬀerence in the inci-
dence of convulsions,  but the incidence tended to be 
higher in the Brewerʼs yeast-treated group compared 
with the saline-control group Fig.  3.  Diazepam dose-
dependently prolonged the onset of aminophylline-
elicited convulsions [pyrogen: F (1,  56)＝9.615,  p＜
0.01; drug: F (2,  59)＝37.824,  p＜0.0001; interac-
tion: F (2,  54)＝0.776,  p＞0.05].  A signiﬁcant dif-
ference (p＜0.05) was shown at a dose of 5mg/kg of 
diazepam.
　 Eﬀects of pentylenetetrazol- and picrotoxin-
induced convulsions in Brewerʼs yeast-treated 
mice. Figs.  4 and 5 illustrate the eﬀect of 
Brewerʼs yeast on convulsions induced by GABAA 
receptor antagonists in mice.  Pentylenetetrazol (40-
60mg/kg,  i.p.) dose-dependently produced clonic con-
vulsions,  and the incidence of convulsions was signiﬁ-
cantly higher (p＜0.01) with pentylenetetrazol at a dose 
of 40mg/kg in Brewerʼs yeast-treated mice.  The 
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Table 1　 Eﬀects of drugs acting on adenosine,  NMDA,  GABA and benzodiazepines receptors against aminophylline-induced convul-
sions in mice
Drug and dose
(mg/kg)
No. convulsed/
no. used
Latency of clonic convulsion
(min)
(mean±S.E.M.)
Saline － 10/10 18.5±2.95
CCPA 1 9/10 17.7±5.00
3 10/10 17.6±1.55
10 9/10 23.6±4.29
Saline － 10/10 13.3±1.96
CPA 3 10/10 10.0±0.82
10 10/10 14.7±2.48
20 10/10 11.9±0.69
CPCA 3 9/10 19.8±5.04
10 9/10 31.4±6.29
20 9/10 19.6±4.88
Muscimol 1 10/10 22.1±4.28
2 7/10 29.9±6.85
4 9/10 23.7±5.71
Baclofen 2 9/10 17.6±5.31
4 8/10 25.7±6.36
Dizocilpine 0.1 10/10 19.5±3.26
0.3 7/10 17.9±2.28
Diazepam 5 0/10## 60.0±0.0＊＊
10 0/10## 60.0±0.0＊＊
＊＊p＜0.01 versus saline control (Dunnettʼs test).
##p＜0.01 versus saline control (Chi-squared test).
All mice were injected aminophylline (350mg/kg,  i.p.) 30min after the drug treatments (i.p.).
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latency of convulsions tended to be shorter at this dose 
of pentylenetetrazol in Brewerʼs yeast-treated mice,  
but two-way ANOVA showed no signiﬁcant diﬀerence 
statistically [pyrogen: F (1,  66)＝2.271,  p＞0.05;  
drug: F (2,  68)＝5.311,  p＞0.05; interaction: F (2,  
54)＝2.362,  p＞0.05].
　 Picrotoxin (3-4mg/kg,  i.p.) elicited clonic convul-
sions in a dose-dependent manner.  Brewerʼs yeast 
signiﬁcantly shortened the onset of the convulsions 
[pyrogen: F (1,  56)＝9.079,  p＜0.01; drug: F (2,  56)
＝14.796,  p＜0.0001; interaction: F (2,  54)＝2.656,  
p＞0.05].  The post hoc comparison using the Studentʼs 
t-test revealed a signiﬁcant reduction in the latency of 
convulsions at a dose of 3.5mg/kg of picrotoxin.
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Fig. 2　 Aminophylline-induced convulsions in Brewerʼs yeast-treated mice.  Each column represents the incidence (%) and the mean 
latency (min) with S.E.M.  of aminophylline-induced convulsions in saline- or Brewerʼs yeast-treated mice (n＝10-18).  ＃p＜0.05,  ＃＃p＜
0.01 (Chi-squared test),  ＊p＜0.05 (two-way ANOVA followed by the Studentʼs t-test).
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Fig. 3　 Anticonvulsant eﬀect of diazepam on aminophylline-induced convulsions in Brewerʼs yeast-treated mice.  Each column repre-
sents the incidence (%) and the mean latency (min) with S.E.M.  of aminophylline (350mg/kg,  i.p.)-induced convulsions in saline- or 
Brewerʼs yeast-treated mice (n＝10).  ＊p＜0.05 (two-way ANOVA followed by the Studentʼs t-test).
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Discussion
　 Fever not only evokes febrile seizures but also 
increases the risk of theophylline-induced convulsions 
in infants and children [15].  The major ﬁndings of the 
present study are that benzodiazepine receptors medi-
ate aminophylline-induced convulsions and the anticon-
vulsant action of diazepam is diminished by pyrexia 
induced by Brewerʼs yeast in mice.
　 Adenosine is known to be an endogenous anticon-
vulsant in the brain [16].  This is supported by ﬁnd-
ings that stimulation of adenosine receptors exerts 
anticonvulsant activity in animal models of seizures 
and that adenosine receptor antagonists such as theo-
phylline and caﬀeine are proconvulsant [17].  A num-
ber of studies have reported that the adenosine A1 
receptor,  but not the adenosine A2 receptor,  reduces 
convulsions induced by kainic acid,  bicuculline,  penty-
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Fig. 5　 Picrotoxin-induced convulsions in Brewerʼs yeast-treated mice.  Each column represents the incidence (%) and the mean latency 
(min) with S.E.M.  of picrotoxin -induced convulsions in saline- or Brewerʼs yeast-treated mice (n＝10).  ＊p＜0.05 (two-way ANOVA fol-
lowed by the Studentʼs t-test).
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Fig. 4　 Pentylenetetrazol-induced convulsions in Brewerʼs yeast-treated mice.  Each column represents the incidence (%) and the mean 
latency (min) with S.E.M.  of pentylenetetrazol-induced convulsions in saline- or Brewerʼs yeast-treated mice (n＝12). ＃＃p＜0.01 (Chi-
squared test).
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lenetetrazol,  chemical kindling and electroconvulsive 
shock [18-20].  However,  a number of studies have 
reported that adenosine A1 receptor agonists fail to 
prevent [21-23] or to protect against theophylline-
induced convulsions [24].  Based on these results,  it 
has been suggested that theophylline-induced seizures 
are produced by mechanisms other than those involving 
the adenosinergic system [21].  In this study,  neither 
the adenosine A1 receptor agonists (CCPA and CPA) 
nor the adenosine A2 receptor agonist CPCA had any 
eﬀect on aminophylline-induced convulsions in ddY 
mice.  On the other hand,  theophylline has been 
reported to inhibit binding of GABA and diazepam to 
GABAA receptors in brain membranes,  although the 
aﬃnities are low [25-26].  Therefore,  it is possible 
that a high dose of theophylline would produce the 
convulsions via GABAA and/or benzodiazepine recep-
tors.
　 GABA is a major inhibitory neurotransmitter in the 
brain,  whereas glutamic acid is an excitatory amino 
acid neurotransmitter.  It is now widely accepted that 
the impairment of GABA neurotransmission by block-
ade of GABAA receptors and the enhancement of glu-
tamic acid neurotransmission by activation of NMDA 
may be the underlying factors in epilepsy [27].  
Amabeoku [28] reported that theophylline (300mg/
kg,  i.p.)-induced convulsions were suppressed by the 
selective GABAA receptor agonist muscimol,  the 
GABAB receptor agonist baclofen,  the GABA uptake 
inhibitor diamino-N-butyric acid (DABA),  and the 
potent inhibitor of GABA transaminase amino-oxya-
cetic acid (AOAA) in female albino mice.  In addition,  
they found that the NMDA receptor antagonists,  
D-AP5 and ketamine,  suppressed theophylline-induced 
convulsions [28].  However,  other investigators have 
reported that the NMDA receptor antagonists,  dizo-
cilpine and ketamine,  were ineﬀective in antagonizing 
the convulsions in male rats and mice,  respectively 
[10,  23].  Thus,  there may be strain diﬀerences in 
the eﬀects of GABA receptor agonists and NMDA 
receptor antagonists against theophylline-induced 
convulsions.  In this study,  muscimol,  baclofen and 
dizocilpine did not have any signiﬁcant eﬀect on the 
convulsions induced by aminophylline in male ddY 
mice.
　 Clinical data indicate that theophylline may induce 
repetitive generalized seizures in asthmatic patients,  
and antiepileptic drugs such as diazepam and pheno-
barbital,  administered at high doses,  can partially 
prevent the convulsions in such cases [29].  Previous 
studies have shown that diazepam and phenobarbital 
antagonize theophylline-induced convulsions in mice,  
but the remaining antiepileptics (acetazolamide,  car-
bamazepine,  diphenylhydantoin,  ethosuximide,  tri-
methadione) are ineﬀective in mice [10].  These ﬁnd-
ings indicate that theophylline-induced convulsions are 
relatively resistant to antiepileptic drugs.  In the pres-
ent study,  diazepam dose-dependently prolonged the 
onset and signiﬁcantly decreased the incidence of 
aminophylline-induced convulsions,  in agreement with 
previous ﬁndings [10,  24,  27,  28].  Therefore,  it is 
suggested that benzodiazepine receptors are involved 
in mediating the convulsant action of aminophylline.
　 In this study,  Brewerʼs yeast increased the body 
temperature of mice,  and also signiﬁcantly shortened 
the onset and signiﬁcantly increased the incidence of 
aminophylline-induced convulsions.  Moreover,  the 
ability of diazepam to ameliorate the aminophylline-
induced convulsions was diminished by Brewerʼs yeast.  
These results indicate that benzodiazepine receptors 
are involved in the mechanism by which Brewerʼs 
yeast-induced pyrexia aggravates aminophylline-elic-
ited convulsions.
　 It is well known that benzodiazepines are agonists 
for the GABAA receptor complex,  and facilitate 
inhibitory GABAergic neurotransmission via the 
enhancement of GABA-induced chloride conductance 
[5].  In the current study,  the proconvulsant actions 
of GABAA receptor antagonists,  picrotoxin and pen-
tylenetetrazol,  were enhanced by Brewerʼs yeast.  
These ﬁndings suggest that GABAA receptor are 
involved in the aggravation of the convulsions by 
Brewerʼs yeast-induced pyrexia.  It has been reported 
that adenosine presynaptically reduces inhibitory 
GABA neurotransmission [30].  Thus,  GABAA rece-
ptors are presumed to be an important nervous system 
component involved in the aggravation of the theophyl-
line-elicited convulsions by pyrexia.  In addition,  fever 
is a systemic response to infection,  inﬂammation,  or 
stress.  Therefore,  further studies will be necessary 
in order to clarify the precise mechanisms of the 
decreased convulsion threshold of theophylline in 
fever.
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